Product Reports Resources Pricing Login Book a demo

N-Power Medicine

Health · United States · Founded 2021

Accelerating oncology innovation with faster drug development and better therapy outcomes MoreLess

N Power Medicine operates in the healthcare sector, specifically focusing on oncology, which is the study and treatment of cancer. The company aims to accelerate the development of cancer therapies, thereby improving patient outcomes. By leveraging advanced technologies and innovative methodologies, N Power Medicine seeks to shorten the drug development timeline, making effective treatments available more quickly. The primary clients are pharmaceutical companies and healthcare providers who are involved in cancer treatment and research. The market it operates in is highly specialized and competitive, with a focus on cutting-edge medical research and drug development. The business model revolves around partnerships and collaborations with pharmaceutical firms and research institutions, generating revenue through service fees, research grants, and possibly licensing agreements for their proprietary technologies.

Keywords: oncology, cancer treatment, drug development, healthcare innovation, pharmaceutical partnerships, therapy outcomes, medical research, advanced technologies, patient care, specialized market.

Company overview

N-Power Medicine company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2021
Headquarters
United States
Employees
113
Open positions
7
Dealroom signal
70.9
Investment activity
1 companies · latest Jan 2025
Capital deployed
Preferred round
ACQUISITION
client focusb2bindustryHealthsectorBiotechnologysectorOncologysectorDrug DevelopmentsectorBiotech and Pharma

Valuation & funding

N-Power Medicine funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BEquity / VC Sep 2026 $32M $128M Merck Global Health Innovation Fund · Innovatus Capital Partners
SERIES BEquity / VC Jul 2024 $0 Merck Global Health Innovation Fund
Showing 2 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 113
2025 118
2024 62
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

N-Power Medicine website traffic

Latest recorded traffic for N-Power Medicine is 1.9K monthly website visits, up 46.2% over the last three months. N-Power Medicine's team declined 4.2% over the past year.

Latest monthly visits1.9K 3-month web change+46.2% 1-year team growth-4.2%
Monthly website visits26 observations · Jun 2024–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

N-Power Medicine compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

N-Power Medicine's talent

Book a demo to see the people
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

3 investors on N-Power Medicine's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 2 investors entered at this stage
Merck Global Health Innovation Fund
Innovatus Capital Partners
Other known 1 additional known investor

Global footprint

Where N-Power Medicine has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about N-Power Medicine

Recent press, funding announcements, and product moves mentioning N-Power Medicine — open to read from the original sources.

See all news

Market sentiment

What the market is saying about N-Power Medicine

An AI-synthesized read of the highest-engagement posts about N-Power Medicine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See N-Power Medicine’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.